![The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082)]()
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082)M.J. O'Sullivan; P.J.J. Boyer; G.B. Scott; W.P. Parks; S. Weller; R. Blum; J. Balsley; Y.J. Bryson; B. Bond; J. Efantis-Potter; S. Gillespie; J. Gourley; A. Helfgott; S. Lai; C. Mitchell; S. O'Rourke; W. Parks; D. Perry-Marx; W. Scott · 1994